摘要
目的:评价黄芪注射液治疗变异型心绞痛的疗效及对患者内皮素-1(Endothelin-1,ET-1)及一氧化氮(Nitric oxide,NO)水平的影响。方法:60例变异型心绞痛患者,按随机数字表法分为观察组和对照组。对照组:采用硝苯地平片、阿司匹林肠溶片及阿托伐他汀钙片治疗。观察组:在对照组方法的基础上,加用黄芪注射液治疗变异型心绞痛。结果:观察组总有效率86.67%高于对照组总有效率63.33%,差异有统计学意义(P<0.05)。与对照组相比,观察组能明显改善ET-1及NO水平,统计学处理,差异有显著性(P<0.01)。与对照组相比,观察组能明显降低心脏事件的发生率,统计学处理,差异有显著性(P<0.05)。结论:黄芪注射液用于治疗变异型心绞痛疗效可靠,并能明显改善变异型心绞痛患者的ET-1及NO水平。
Objective:To made therapeutic evaluation of Astragalus Injection in the treatment of variant angina pectoris and its influence on Endothelin-1(ET-1) and nitric oxide(NO).Methods:60 cases of patients with variant angina pectoris were divided into the observation group and the control group.The control group:nifedipine tablets,enteric-coated tablets of aspirin and atorvastatin calcium tablets treatment of variant angina pectoris.The observation group:on the basis of the control group method,added Astragalus Injection in the treatment of variant angina pectoris.Results:The total efficiency of the observation group was 86.67% which was higher than 63.33% of the control group,with significant difference(P0.05).Compared with the control group,the observation group can improve the levels of ET-1 and NO,with statistically significant difference(P0.01).Compared with the control group,the observation group could reduce the incidence of cardiac events,with statistically significant difference(P0.05).Conclusion:Astragalus Injection has reliable curative effect for the treatment of variant angina pectoris,and can obviously improve the ET-1 and NO of patients with variant angina.
出处
《中华中医药学刊》
CAS
2013年第5期1156-1158,共3页
Chinese Archives of Traditional Chinese Medicine
基金
平湖市金桥工程资助项目(201225)
关键词
变异型心绞痛
心痛
黄芪注射液
内皮素
一氧化氮
variant angina pectorispain
cardiac pain
Astragalus Injection
endothelin
nitric oxide